Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$2.06
+4.57%
Mkt Cap $158.87M
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
Implied Upside
+737.4%
Consensus $17.25 vs current $2.06
NASDAQ·Healthcare·Biotechnology
$2.06
+4.57%
Mkt Cap $158.87M
Buy
7
Hold
1
Sell
0
Price Target (13 analysts)
$17.25
Range $12.00 – $28.00
+737.4%
Consensus $17.25 vs current $2.06